TheraGenetics Technology

We don't create drugs we just make sure the right people take them

TheraGenetics technology for treatment individualization promises multiple benefits for the treatment of CNS disorders. Our vision is to introduce personalised medicine into day-to-day clinical practice so that genetic information is used to inform prescribing decisions and better treat these complex and disabling disorders.

TheraGenetics technology uses pharmacogenetics, the study of how the genetic variation between individuals alters medication response, to develop diagnostic tests for the prediction of clinical response and side effects to CNS treatments. Our genetic response prediction tests combine data from multiple genetic variants that we have identified as being responsible for determining treatment outcome. This innovative technology has unique benefits for patient care, clinical trials and drug development and repositioning.